These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

211 related items for PubMed ID: 8621805

  • 1. Combined administration of recombinant human megakaryocyte growth and development factor and granulocyte colony-stimulating factor enhances multilineage hematopoietic reconstitution in nonhuman primates after radiation-induced marrow aplasia.
    Farese AM, Hunt P, Grab LB, MacVittie TJ.
    J Clin Invest; 1996 May 01; 97(9):2145-51. PubMed ID: 8621805
    [Abstract] [Full Text] [Related]

  • 2. Simultaneous administration of TPO and G-CSF after cytoreductive treatment of rhesus monkeys prevents thrombocytopenia, accelerates platelet and red cell reconstitution, alleviates neutropenia, and promotes the recovery of immature bone marrow cells.
    Neelis KJ, Dubbelman YD, Qingliang L, Thomas GR, Eaton DL, Wagemaker G.
    Exp Hematol; 1997 Sep 01; 25(10):1084-93. PubMed ID: 9293906
    [Abstract] [Full Text] [Related]

  • 3. Effects of combined administration of interleukin-6 and granulocyte colony-stimulating factor on recovery from radiation-induced hemopoietic aplasia.
    Patchen ML, Fischer R, MacVittie TJ.
    Exp Hematol; 1993 Feb 01; 21(2):338-44. PubMed ID: 7678816
    [Abstract] [Full Text] [Related]

  • 4. Leridistim, a chimeric dual G-CSF and IL-3 receptor agonist, enhances multilineage hematopoietic recovery in a nonhuman primate model of radiation-induced myelosuppression: effect of schedule, dose, and route of administration.
    Farese AM, Casey DB, Smith WG, Vigneulle RM, McKearn JP, MacVittie TJ.
    Stem Cells; 2001 Feb 01; 19(6):522-33. PubMed ID: 11713344
    [Abstract] [Full Text] [Related]

  • 5. Lack of efficacy of thrombopoietin and granulocyte colony-stimulating factor after high dose total-body irradiation and autologous stem cell or bone marrow transplantation in rhesus monkeys.
    Neelis KJ, Dubbelman YD, Wognum AW, Thomas GR, Eaton DL, Egeland T, Wagemaker G.
    Exp Hematol; 1997 Sep 01; 25(10):1094-103. PubMed ID: 9293907
    [Abstract] [Full Text] [Related]

  • 6. Hematopoietic recovery following autologous bone marrow transplantation in a nonhuman primate: effect of variation in treatment schedule with PEG-rHuMGDF.
    Farese AM, MacVittie TJ, Roskos L, Stead RB.
    Stem Cells; 2003 Sep 01; 21(1):79-89. PubMed ID: 12529554
    [Abstract] [Full Text] [Related]

  • 7. Multilineage hematopoietic recovery by a single injection of pegylated recombinant human megakaryocyte growth and development factor in myelosuppressed mice.
    Shibuya K, Akahori H, Takahashi K, Tahara E, Kato T, Miyazaki H.
    Blood; 1998 Jan 01; 91(1):37-45. PubMed ID: 9414267
    [Abstract] [Full Text] [Related]

  • 8. Thrombopoietin: biology and clinical potentials.
    Miyazaki H, Kato T.
    Int J Hematol; 1999 Dec 01; 70(4):216-25. PubMed ID: 10643146
    [Abstract] [Full Text] [Related]

  • 9. Synergistic effects of pegylated recombinant human megakaryocyte growth and development factor and granulocyte colony-stimulating factor on mobilization of hematopoietic progenitor and stem cells with long-term repopulating ability into peripheral blood in mice.
    Honda K, Takenaka K, Shinagawa K, Ishimaru F, Ikeda K, Niiya K, Harada M.
    Bone Marrow Transplant; 2001 Aug 01; 28(4):329-34. PubMed ID: 11571503
    [Abstract] [Full Text] [Related]

  • 10. Combination therapy for radiation-induced bone marrow aplasia in nonhuman primates using synthokine SC-55494 and recombinant human granulocyte colony-stimulating factor.
    MacVittie TJ, Farese AM, Herodin F, Grab LB, Baum CM, McKearn JP.
    Blood; 1996 May 15; 87(10):4129-35. PubMed ID: 8639770
    [Abstract] [Full Text] [Related]

  • 11. The efficacy of single-dose administration of thrombopoietin with coadministration of either granulocyte/macrophage or granulocyte colony-stimulating factor in myelosuppressed rhesus monkeys.
    Neelis KJ, Hartong SC, Egeland T, Thomas GR, Eaton DL, Wagemaker G.
    Blood; 1997 Oct 01; 90(7):2565-73. PubMed ID: 9326222
    [Abstract] [Full Text] [Related]

  • 12. Recovery from severe hematopoietic suppression using recombinant human granulocyte-macrophage colony-stimulating factor.
    Monroy RL, Skelly RR, Taylor P, Dubois A, Donahue RE, MacVittie TJ.
    Exp Hematol; 1988 Jun 01; 16(5):344-8. PubMed ID: 3286278
    [Abstract] [Full Text] [Related]

  • 13. In vivo effects of pegylated recombinant human megakaryocyte growth and development factor on hematopoiesis in normal mice.
    Kabaya K, Akahori H, Shibuya K, Nitta Y, Ida M, Kusaka M, Kato T, Miyazaki H.
    Stem Cells; 1996 Nov 01; 14(6):651-60. PubMed ID: 8948023
    [Abstract] [Full Text] [Related]

  • 14. An analysis of the effects of combined treatment with rmGM-CSF and PEG-rHuMGDF in murine bone marrow transplant recipients.
    Molineux G, Hartley C, McElroy P, McCrea C, Kerzic P, McNiece I.
    Stem Cells; 1997 Nov 01; 15(1):43-9. PubMed ID: 9007221
    [Abstract] [Full Text] [Related]

  • 15. Effects of pegylated recombinant human megakaryocyte growth and development factor on thrombocytopenia induced by a new myelosuppressive chemotherapy regimen in mice.
    Akahori H, Shibuya K, Ozai M, Ida M, Kabaya K, Kato T, Miyazaki H.
    Stem Cells; 1996 Nov 01; 14(6):678-89. PubMed ID: 8948025
    [Abstract] [Full Text] [Related]

  • 16. Systemic effects of pegylated recombinant human megakaryocyte growth and development factor in combination with recombinant murine granulocyte colony-stimulating factor in a murine model of myelosuppression.
    Coleman D, Fairchild D, Schindler-Horvat J, Munyakazi L, Neumann TA.
    Toxicol Sci; 1998 Sep 01; 45(1):77-87. PubMed ID: 9848114
    [Abstract] [Full Text] [Related]

  • 17. Ex vivo expansion of megakaryocyte progenitors: effect of various growth factor combinations on CD34+ progenitor cells from bone marrow and G-CSF-mobilized peripheral blood.
    Gehling UM, Ryder JW, Hogan CJ, Hami L, McNiece I, Franklin W, Williams S, Helm K, King J, Shpall EJ.
    Exp Hematol; 1997 Oct 01; 25(11):1125-39. PubMed ID: 9328449
    [Abstract] [Full Text] [Related]

  • 18. Comparison of autologous cell therapy and granulocyte-colony stimulating factor (G-CSF) injection vs. G-CSF injection alone for the treatment of acute radiation syndrome in a non-human primate model.
    Bertho JM, Frick J, Prat M, Demarquay C, Dudoignon N, Trompier F, Gorin NC, Thierry D, Gourmelon P.
    Int J Radiat Oncol Biol Phys; 2005 Nov 01; 63(3):911-20. PubMed ID: 15913916
    [Abstract] [Full Text] [Related]

  • 19. Therapeutic administration of recombinant human granulocyte colony-stimulating factor accelerates hemopoietic regeneration and enhances survival in a murine model of radiation-induced myelosuppression.
    Patchen ML, MacVittie TJ, Solberg BD, Souza LM.
    Int J Cell Cloning; 1990 Mar 01; 8(2):107-22. PubMed ID: 1690250
    [Abstract] [Full Text] [Related]

  • 20. Improvement of thrombocytopenia following bone marrow transplantation by pegylated recombinant human megakaryocyte growth and development factor in mice.
    Kabaya K, Shibuya K, Torii Y, Nitta Y, Ida M, Akahori H, Kato T, Kusaka M, Miyazaki H.
    Bone Marrow Transplant; 1996 Dec 01; 18(6):1035-41. PubMed ID: 8971370
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.